HTT-lowering is accepted as a viable therapeutic paradigm for the treatment of HD.52,53,76 Recent technological advances allow highly-efficient modulation of huntingtin expression at the post-transcriptional level—i.e. This evidence concerns the gene HTT and Huntington disease.